Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 41
A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine.
Times cited: 2
Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.
American journal of hematology.
Times cited: 5